Invention Grant
- Patent Title: Muscarinic combinations and their use for combating hypocholinergic disorders of the central nervous system
-
Application No.: US15260996Application Date: 2016-09-09
-
Publication No.: US10307409B2Publication Date: 2019-06-04
- Inventor: Thomas N. Chase , Kathleen E. Clarence-Smith
- Applicant: Chase Pharmaceuticals Corporation
- Applicant Address: US DC Washington
- Assignee: Chase Pharmaceuticals Corporation
- Current Assignee: Chase Pharmaceuticals Corporation
- Current Assignee Address: US DC Washington
- Agent Roy Issac
- Main IPC: A61K31/167
- IPC: A61K31/167 ; A61K31/216 ; A61K31/439 ; A61K31/517 ; A61K31/4178 ; A61K31/4439 ; A61K31/4725 ; A61K31/454 ; A61K9/70 ; A61K45/06 ; A61K9/00 ; A61K31/166 ; A61K31/44
Abstract:
A combination of a muscarinic cholinergic receptor agonist, a non-anticholinergic antiemetic agent and a non-selective, peripheral anticholinergic agent for the treatment of hypocholinergic disorders of the central nervous system.
Public/Granted literature
Information query
